Production of valienamine by a newly isolated strain: Stenotrophomonas maltrophilia

Enzyme and Microbial Technology

Volumn 39, Issue 5, 2006, Pages 1060-1065

  Zheng, Yu Guo ^a   Xue, Ya Ping ^a   Shen, Yin Chu ^a  

^a ZHEJIANG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Enzyme inhibitor; Stenotrophomonas maltrophilia; Validamycin A; Valienamine

Indexed keywords

BACTERIA; BIOREACTORS; CARBON; ENZYME INHIBITION; FERMENTATION; NITROGEN; SYNTHESIS (CHEMICAL); THERMAL EFFECTS;

BACTERIAL STRAINS; STENOTROPHOMONAS MALTROPHILIA; VALIDAMYCIN A; VALIENAMINE;

ALCOHOLS;

AMINOCYCLITOL; AMMONIUM SULFATE; CARBON; NITROGEN; UNCLASSIFIED DRUG; VALIDAMYCIN A; VALIDAMYCIN DERIVATIVE; VALIENAMINE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; CARBON SOURCE; CONTROLLED STUDY; DRUG DEGRADATION; DRUG DESIGN; FERMENTATION; NONHUMAN; PH MEASUREMENT; STENOTROPHOMONAS MALTOPHILIA; STIRRED REACTOR; TEMPERATURE DEPENDENCE;

BACTERIA (MICROORGANISMS); STENOTROPHOMONAS;

EID: 33745951275     PISSN: 01410229     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.enzmictec.2006.02.004     Document Type: Article

References (26)

1. Kameda Y., and Horii S. The unsaturated cyclitol part of the new antibiotics, the validamycins. J Chem Soc Chem Commun 12 (1972) 746-747
2. Kameda Y., Asano N., Yoshikawa M., and Matsui K. Valienamine as an alpha-glucosidase inhibitor. J Antibiot 33 (1980) 1575-1576
3. Takeuchi M., Kamata K., Yoshida M., Kameda Y., and Matsuim K. Inhibitory effect of pseudo-aminosugars on oligosaccharide glucosidases I and II and on lysosomal alpha-glucosidase from rat liver. J Antibiot 108 (1990) 42-45
4. Takeuchi M., Takai N., Asano N., Kameda Y., and Matsui K. Inhibitory effect of validamine, valienamine and valiolamine on activities of carbohydrases in rat small intestinal brush border membranes. Chem Pharm Bull 38 (1990) 1970-1975
5. 7N unit not derived from the shikimate pathway. J Antibiot 40 (1987) 855-861
6. Horii S., Fukase H., and Kameda Y. Stereoselective conversion of valienamine and validamine into valiolamine. Carbohydr Res 140 (1985) 185-200
7. ®), an antidiabetic agent. J Synth Org Chem 55 (1997) 920-925
8. ®, AO-128), one of the most important alpha-glucosidase inhibitors. Curr Med Chem 13 (2006) 109-116
9. Yokose K., Ogawa K., Sano T., Watanabe K., Maruyama H.B., and Suhara Y. New alpha-amylase inhibitor, trestatins I. Isolation, characterization and biological activities of trestatins A, B and C. J Antibiot 36 (1983) 1157-1165
10. Ogawa S., Ashiura M., Uchiuda C., Watanabe S., Yamazaki C., Yamagishi K., et al. Synthesis of potent β-d-glucocrebrosidase inhibitors: N-alkyl-β-valienamines. Bioorg Med Chem Lett 6 (1996) 929-932
11. Furumoto S., Kameda Y., and Matsui K. Enzymatic synthesis of glucoside derivatives of validamine and valienamine. Chem Pharm Bull 40 (1992) 1871-1875
12. Ogawa S., Ikeda N., Takeda H., and Nakagawa Y. Synthesis of some valienamine epoxides: on the structure of the alpha-amylase inhibitor NS-504. Carbohydr Res 175 (1988) 294-301
13. Chen X.L., Fan Y.X., Zheng Y.G., and Shen Y.C. Properties and production of valienamine and its related analogues. Chem Rev 103 (2003) 1955-1977
14. Agricultural Antibiotic Group in Shanghai Pesticide Institute. Classification and identification of Jinggangmycin producing strains. Acta Microbiol 15 (1975) 110-114 (in Chinese)
15. Iwasa T., Yamamoto H., and Shibata M. Studies on validamycins, new antibiotics I. Streptomyces hygroscopicus var. limoneus. validamycin producing organism. J Antibiot 23 (1970) 595-602
16. Kameda Y., Horri S., and Yamino T. Microbial transformation of validamycins. J Anitibiot 28 (1975) 298-306
17. Zheng Y.G., Zhang X.F., and Shen Y.C. Microbial transformation of validamycin A to valienamine by immobilized cells. Biocatal Biotransform 23 (2005) 71-77
18. Kameda Y., Asano N., Teranishi M., and Matsui K. New cyclitols, degradation of validamycin A by Flavobacterium saccharophilum. J Antibiot 33 (1980) 1573-1574
19. Kameda Y., Asano N., Teranishi M., Yoshikawa M., and Matsui K. New intermediates, degradation of validamycin A by Flavobacterium saccharophilum. J Antibiot 34 (1981) 1237-1241
20. Zhang JF, Zheng YG, Xue YP, Shen YC. Purification and characterization of the glucoside 3-dehydrogenase produced by a newly isolated Stenotrophomonas maltrophilia CCTCC M 204024. Appl Microbiol Biotechnol 2005, online published.
21. Zheng Y.G., Chen X.L., Wang Z., and Shen Y.C. Production of validamycins from crude substrates by Streptomyces hygroscopicus in an external-loop airlift bioreactor with a low height-to-diameter ratio. Chin J Chem Eng 12 (2004) 102-107
22. Zheng Y.G., Jin L.Q., and Shen Y.C. Resin-catalyzed degradation of validamycin A for production of validoxylamine A. Catal Commun 5 (2004) 519-525
23. Xue Y.P., Zheng Y.G., and Shen Y.C. Preparation of trehalase inhibitor validoxylamine A by biocatalyzed hydrolysis of validamycin A with honeybee (Apis cerana Fabr.) β-glucosidase. Appl Biochem Biotechnol 127 (2005) 157-171
24. Horii S, Kameda Y. Pseudo-aminosugars, their production and use. 1982; EP0063456.
25. Zheng Y.G., Shentu X.P., and Shen Y.C. Inhibition of porcine small intestinal sucrase by valienamine. J Enzyme Inhib Med Chem 20 (2005) 49-53
26. Cooper C.M., Fernstrom G.A., and Miller S.A. Performance of agitated gas-liquid contactors. Ind Eng Chem 36 (1944) 504-509